Učitavanje...
RNA Interference-Based Cancer Drugs: The Roadblocks, and the “Delivery” of the Promise
Nucleic acid-based therapeutics like synthetic small interfering RNAs have been exploited to modulate gene function, taking advantage of RNA interference (RNAi), an evolutionally conserved biological process. Recently, the world's first RNAi drug was approved for a rare genetic disorder in the...
Spremljeno u:
| Izdano u: | Nucleic Acid Ther |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Mary Ann Liebert, Inc., publishers
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6461149/ https://ncbi.nlm.nih.gov/pubmed/30562145 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/nat.2018.0762 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|